Latest Period
Q2 2026
Security Snapshot
Nanobiotix S.A. - Ordinary shares, nominal value Euro 0.03 per share (NBTX) Institutional Ownership
CUSIP: 63009J107
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
19
Shares (Excl. Options)
5,792,537
Price
$37.70
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary shares, nominal value Euro 0.03 per share
- Symbol
- NBTX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 5,792,537
- Total 13F value
- $218,375,724
- Portfolio coverage rank
- 0%
- Share change
- +93,943
- Value change
- +$3,541,871
- Number of holders
- 19
- Shares outstanding
- 51,365,681
- SEC-reported price per share
- $40.16
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NBTX - Nanobiotix S.A. - Ordinary shares, nominal value Euro 0.03 per share is tracked under CUSIP 63009J107.
- 19 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 15 to 19 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $175,900,273 to $218,375,724.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 19 institutions filings for Q2 2026.
Security key
63009J107
Latest holder period
Q2 2026
13F holders
19
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
NBTX full holder history
Nanobiotix S.A. SEC filings
Nanobiotix S.A. company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 63009J107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
NBTX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 9.4% | +5.6% | $193,472,946 | +$23,863,488 | 4,828,374 | +14% | Invus Public Equities, L.P. | 30 Jun 2026 |
| Qatar Investment Authority | 7% | $133,177,657 | 3,532,517 | Qatar Investment Authority | 30 Jun 2026 | |||
| BAILLIE GIFFORD & CO | 4.1% | $6,142,944 | 1,919,670 | BAILLIE GIFFORD & CO | 31 Dec 2024 |
As of 30 Jun 2026, 19 institutional investors reported holding 5,792,537 shares of Nanobiotix S.A. - Ordinary shares, nominal value Euro 0.03 per share (NBTX). This represents 11% of the company’s total 51,365,681 outstanding shares.
13F concentration
Top 22 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
11%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 11% | 5,623,816 | 0% | 27% | $212,017,863 |
| MORGAN STANLEY | 0.1% | 49,789 | +37% | 0% | $1,877,045 |
| JANE STREET GROUP, LLC | 0.06% | 32,180 | 0% | $1,213,186 | |
| HRT FINANCIAL LP | 0.05% | 27,332 | 0% | $1,030,000 | |
| XTX Topco Ltd | 0.03% | 15,855 | 0.01% | $597,734 | |
| Optiver Holding B.V. | 0.03% | 13,631 | +0.96% | 0.01% | $513,889 |
| MARSHALL WACE, LLP | 0.02% | 10,044 | +8.7% | 0% | $378,659 |
| CITADEL ADVISORS LLC | 0.01% | 6,042 | 0% | $227,783 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.01% | 4,044 | 0% | 0% | $152,459 |
| UBS Group AG | 0.01% | 2,577 | -54% | 0% | $97,153 |
| ROYAL BANK OF CANADA | 0% | 2,189 | +20% | 0% | $83,000 |
| JPMORGAN CHASE & CO | 0% | 1,706 | 0% | $61,348 | |
| RHUMBLINE ADVISERS | 0% | 1,502 | -34% | 0% | $56,622 |
| GAMMA Investing LLC | 0% | 985 | +19% | 0% | $37,135 |
| OSAIC HOLDINGS, INC. | 0% | 500 | 0% | 0% | $18,850 |
| WELLS FARGO & COMPANY/MN | 0% | 200 | 0% | 0% | $7,540 |
| Stone House Investment Management, LLC | 0% | 76 | 0% | $2,865 | |
| Federation des caisses Desjardins du Quebec | 0% | 56 | 0% | $2,111 | |
| NATIONAL BANK OF CANADA /FI/ | 0% | 13 | 0% | 0% | $482 |
| CITIGROUP INC | 0% | 0 | -100% | $0 | |
| EverSource Wealth Advisors, LLC | 0% | 0 | -100% | $0 | |
| Tower Research Capital LLC (TRC) | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 5,792,537 | $218,375,724 | +$3,541,871 | $37.70 | 19 |
| 2026 Q1 | 5,698,109 | $175,900,273 | +$46,423 | $30.87 | 15 |
| 2025 Q4 | 5,700,886 | $131,804,789 | +$1,261,855 | $23.12 | 14 |
| 2025 Q3 | 5,644,984 | $106,633,384 | +$3,288 | $18.89 | 11 |
| 2025 Q2 | 5,645,042 | $25,554,914 | -$414,807 | $4.73 | 8 |
| 2025 Q1 | 5,761,181 | $20,624,582 | -$1,004,115 | $3.58 | 10 |
| 2024 Q4 | 6,067,225 | $17,419,035 | -$1,000,406 | $2.87 | 16 |
| 2024 Q3 | 6,417,922 | $36,903,052 | -$14,323,739 | $5.75 | 9 |
| 2024 Q2 | 9,293,451 | $46,466,940 | -$68,645 | $5.00 | 11 |
| 2024 Q1 | 9,306,982 | $59,748,622 | +$230,299 | $6.50 | 11 |
| 2023 Q4 | 9,271,406 | $67,496,071 | +$33,478,773 | $7.28 | 12 |
| 2023 Q3 | 4,468,338 | $39,097,959 | +$8,789,679 | $8.75 | 9 |
| 2023 Q2 | 3,463,804 | $17,715,486 | +$5,090 | $5.07 | 5 |
| 2023 Q1 | 3,462,800 | $12,353,370 | -$3,852 | $3.52 | 4 |
| 2022 Q4 | 3,463,881 | $12,194,444 | +$2,929 | $3.67 | 5 |
| 2022 Q3 | 3,463,083 | $12,218,000 | -$49,000 | $3.54 | 5 |
| 2022 Q2 | 3,476,092 | $13,278,000 | -$18,904 | $3.78 | 6 |
| 2022 Q1 | 3,481,131 | $25,974,000 | -$293,544 | $7.25 | 6 |
| 2021 Q4 | 3,520,885 | $28,772,000 | -$6,268,938 | $8.10 | 7 |
| 2021 Q3 | 4,094,109 | $46,466,000 | -$10,429,241 | $11.36 | 9 |
| 2021 Q2 | 4,852,401 | $66,866,000 | -$203,431 | $13.78 | 10 |
| 2021 Q1 | 4,867,161 | $73,173,000 | -$987,342 | $15.04 | 10 |
| 2020 Q4 | 4,926,653 | $81,291,000 | +$81,291,000 | $16.50 | 11 |